162 related articles for article (PubMed ID: 18329774)
1. Scaling-up antiretroviral treatment in Southern African countries with human resource shortage: how will health systems adapt?
Van Damme W; Kober K; Kegels G
Soc Sci Med; 2008 May; 66(10):2108-21. PubMed ID: 18329774
[TBL] [Abstract][Full Text] [Related]
2. The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020.
Dutta A; Barker C; Kallarakal A
PLoS Med; 2015 Nov; 12(11):e1001907; discussion e1001907. PubMed ID: 26599990
[TBL] [Abstract][Full Text] [Related]
3. Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study.
Nkhata MJ; Muzambi M; Ford D; Chan AK; Abongomera G; Namata H; Mambule I; South A; Revill P; Grundy C; Mabugu T; Chiwaula L; Hakim J; Kityo C; Reid A; Katabira E; Sodhi S; Gilks CF; Gibb DM; Seeley J; Cataldo F;
BMC Health Serv Res; 2016 Nov; 16(1):660. PubMed ID: 27852291
[TBL] [Abstract][Full Text] [Related]
4. Community-based antiretroviral therapy programs can overcome barriers to retention of patients and decongest health services in sub-Saharan Africa: a systematic review.
Decroo T; Rasschaert F; Telfer B; Remartinez D; Laga M; Ford N
Int Health; 2013 Sep; 5(3):169-79. PubMed ID: 24030268
[TBL] [Abstract][Full Text] [Related]
5. Community-supported models of care for people on HIV treatment in sub-Saharan Africa.
Bemelmans M; Baert S; Goemaere E; Wilkinson L; Vandendyck M; van Cutsem G; Silva C; Perry S; Szumilin E; Gerstenhaber R; Kalenga L; Biot M; Ford N
Trop Med Int Health; 2014 Aug; 19(8):968-77. PubMed ID: 24889337
[TBL] [Abstract][Full Text] [Related]
6. Introduction: the realities of antiretroviral therapy rollout: overcoming challenges to successful programmatic implementation.
Ojikutu B
J Infect Dis; 2007 Dec; 196 Suppl 3():S445-8. PubMed ID: 18181692
[TBL] [Abstract][Full Text] [Related]
7. Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness.
Hontelez JA; Chang AY; Ogbuoji O; de Vlas SJ; Bärnighausen T; Atun R
AIDS; 2016 Sep; 30(15):2341-50. PubMed ID: 27367487
[TBL] [Abstract][Full Text] [Related]
8. Tackling health workforce shortages during antiretroviral treatment scale-up--experiences from Ethiopia and Malawi.
Rasschaert F; Philips M; Van Leemput L; Assefa Y; Schouten E; Van Damme W
J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 2():S109-12. PubMed ID: 21857292
[TBL] [Abstract][Full Text] [Related]
9. Expanding access to antiretroviral therapy in sub-saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities.
McCoy D; Chopra M; Loewenson R; Aitken JM; Ngulube T; Muula A; Ray S; Kureyi T; Ijumba P; Rowson M
Am J Public Health; 2005 Jan; 95(1):18-22. PubMed ID: 15623853
[TBL] [Abstract][Full Text] [Related]
10. Healthcare utilization of patients accessing an African national treatment program.
Harling G; Orrell C; Wood R
BMC Health Serv Res; 2007 Jun; 7():80. PubMed ID: 17555564
[TBL] [Abstract][Full Text] [Related]
11. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
[TBL] [Abstract][Full Text] [Related]
12. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care.
Bedelu M; Ford N; Hilderbrand K; Reuter H
J Infect Dis; 2007 Dec; 196 Suppl 3():S464-8. PubMed ID: 18181695
[TBL] [Abstract][Full Text] [Related]
13. Equity in the national rollout of public AIDS treatment in South Africa 2004-08.
McLaren ZM
Health Policy Plan; 2015 Nov; 30(9):1162-72. PubMed ID: 25500558
[TBL] [Abstract][Full Text] [Related]
14. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
[TBL] [Abstract][Full Text] [Related]
15. [Community organizations and fighting STDs, HIV and AIDS in Montreal: lessons for sub-Saharan Africa].
Agonnoude MT; Mesenge C
Sante; 2010; 20(2):116-24. PubMed ID: 20685643
[TBL] [Abstract][Full Text] [Related]
16. The challenges to scaling up antiretroviral therapy in Papua New Guinea.
Raynes P; Maibani G
P N G Med J; 2006; 49(1-2):32-42. PubMed ID: 18396610
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of highly active antiretroviral therapy in South Africa.
Badri M; Maartens G; Mandalia S; Bekker LG; Penrod JR; Platt RW; Wood R; Beck EJ
PLoS Med; 2006 Jan; 3(1):e4. PubMed ID: 16318413
[TBL] [Abstract][Full Text] [Related]
18. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa.
Barker C; Dutta A; Klein K
J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21648. PubMed ID: 28770597
[TBL] [Abstract][Full Text] [Related]
19. The impact of ART (anti-retroviral treatment) scale-up on health systems de-strengthening in sub-Saharan Africa: justice and justification.
Nixon S; Veenstra N
Med Law; 2008 Sep; 27(3):685-703. PubMed ID: 19004389
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
